209 related articles for article (PubMed ID: 33421291)
21. Lupus anticoagulant antibodies: recognition of phospholipid-binding protein complexes.
Rauch J
Lupus; 1998; 7 Suppl 2():S29-31. PubMed ID: 9814668
[TBL] [Abstract][Full Text] [Related]
22. Anti-β
Szabó G; Debreceni IB; Tarr T; Soltész P; Østerud B; Kappelmayer J
Thromb Res; 2021 Jan; 197():124-131. PubMed ID: 33212379
[TBL] [Abstract][Full Text] [Related]
23. Associations with thrombosis are stronger for antiphosphatidylserine/prothrombin antibodies than for the Sydney criteria antiphospholipid antibody tests in SLE.
Elbagir S; Grosso G; Mohammed NA; Elshafie AI; Elagib EM; Zickert A; Manivel VA; Pertsinidou E; Nur MAM; Gunnarsson I; Rönnelid J; Svenungsson E
Lupus; 2021 Jul; 30(8):1289-1299. PubMed ID: 33957795
[TBL] [Abstract][Full Text] [Related]
24. Coagulation tests and anti-phospholipid antibodies in patients positive for lupus anticoagulant.
Sakakura M; Wada H; Watanabe R; Mamamuro M; Okugawa Y; Nakasaki T; Nakase T; Wakita Y; Minamikawa K; Mori Y; Nshikawa M; Shiku H
Clin Appl Thromb Hemost; 2000 Jul; 6(3):144-50. PubMed ID: 10898274
[TBL] [Abstract][Full Text] [Related]
25. Estimation of anticardiolipin antibodies, anti-beta2 glycoprotein I antibodies and lupus anticoagulant in a prospective longitudinal study of children with juvenile idiopathic arthritis.
Avcin T; Ambrozic A; Bozic B; Accetto M; Kveder T; Rozman' B
Clin Exp Rheumatol; 2002; 20(1):101-8. PubMed ID: 11892692
[TBL] [Abstract][Full Text] [Related]
26. Self-interaction of soluble and surface-bound beta2-glycoprotein I and its enhancement by lupus anticoagulants.
Hayashi A; Hayashi A; Matsuura E; Suzuki K; Koike T; Hashimoto E; Takeya H
FEBS Lett; 2008 Oct; 582(23-24):3308-12. PubMed ID: 18822289
[TBL] [Abstract][Full Text] [Related]
27. An international multicentre-laboratory evaluation of a new assay to detect specifically lupus anticoagulants dependent on the presence of anti-beta2-glycoprotein autoantibodies.
De Laat B; Derksen RH; Reber G; Musial J; Swadzba J; Bozic B; Cucnik S; Regnault V; Forastiero R; Woodhams BJ; De Groot PG
J Thromb Haemost; 2011 Jan; 9(1):149-53. PubMed ID: 20874780
[TBL] [Abstract][Full Text] [Related]
28. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
Viveros ME; Cabiedes J; Reyes E; Cabral AR
Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
[TBL] [Abstract][Full Text] [Related]
29. Synergistic thrombotic risk of antibodies against phosphatidylserine and prothrombin and β-2-glycoprotein I.
Kim H; Kim JE; Hwang SM; Lee HR; Han KS; Kim HK
Clin Appl Thromb Hemost; 2014 May; 20(4):442-7. PubMed ID: 23892687
[TBL] [Abstract][Full Text] [Related]
30. The presence of IgG antibodies against beta2-glycoprotein I predicts the risk of thrombosis in patients with the lupus anticoagulant.
Zoghlami-Rintelen C; Vormittag R; Sailer T; Lehr S; Quehenberger P; Rumpold H; Male C; Pabinger I
J Thromb Haemost; 2005 Jun; 3(6):1160-5. PubMed ID: 15946204
[TBL] [Abstract][Full Text] [Related]
31. Relationship of anti beta2-glycoprotein I and anti prothrombin antibodies to thrombosis and pregnancy loss in patients with antiphospholipid antibodies.
Forastiero RR; Martinuzzo ME; Cerrato GS; Kordich LC; Carreras LO
Thromb Haemost; 1997 Sep; 78(3):1008-14. PubMed ID: 9308745
[TBL] [Abstract][Full Text] [Related]
32. A novel mechanism of thrombosis in antiphospholipid antibody syndrome.
Vlachoyiannopoulos PG; Routsias JG
J Autoimmun; 2010 Nov; 35(3):248-55. PubMed ID: 20638238
[TBL] [Abstract][Full Text] [Related]
33. Coexistence of anti-β2-glycoprotein I domain I and anti-phosphatidylserine/prothrombin antibodies suggests strong thrombotic risk.
Lee JS; Gu J; Park HS; Yoo HJ; Kim HK
Clin Chem Lab Med; 2017 May; 55(6):882-889. PubMed ID: 28002027
[TBL] [Abstract][Full Text] [Related]
34. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome.
Arvieux J; Renaudineau Y; Mane I; Perraut R; Krilis SA; Youinou P
Thromb Haemost; 2002 Apr; 87(4):599-605. PubMed ID: 12008941
[TBL] [Abstract][Full Text] [Related]
35. [Pathogenesis and Laboratory Findings in Antiphospholipid Syndrome, Especially Associated with Lupus Anticoagulant].
Ieko M; Naito S; Yoshida M; Takahashi N
Rinsho Byori; 2015 Oct; 63(10):1220-7. PubMed ID: 26897860
[TBL] [Abstract][Full Text] [Related]
36. Revisiting antiphospholipid antibodies: from targeting phospholipids to phospholipid binding proteins.
Bertolaccini ML; Hughes GR; Khamashta MA
Clin Lab; 2004; 50(11-12):653-65. PubMed ID: 15575307
[TBL] [Abstract][Full Text] [Related]
37. Heterogeneity of lupus anticoagulant (LA) antibodies: LA activity in dilute Russell's Viper Venom Time and dilute Kaolin Clotting Time detect different populations of antibodies in patients with the "antiphospholipid" syndrome.
Kandiah DA; Krilis SA
Thromb Haemost; 1998 Aug; 80(2):250-7. PubMed ID: 9716148
[TBL] [Abstract][Full Text] [Related]
38. Correlation between antiphospholipid antibodies that recognize domain I of beta2-glycoprotein I and a reduction in the anticoagulant activity of annexin A5.
de Laat B; Wu XX; van Lummel M; Derksen RH; de Groot PG; Rand JH
Blood; 2007 Feb; 109(4):1490-4. PubMed ID: 17053060
[TBL] [Abstract][Full Text] [Related]
39. Complexes of anti-prothrombin antibodies and prothrombin cause lupus anticoagulant activity by competing with the binding of clotting factors for catalytic phospholipid surfaces.
Simmelink MJ; Horbach DA; Derksen RH; Meijers JC; Bevers EM; Willems GM; De Groot PG
Br J Haematol; 2001 Jun; 113(3):621-9. PubMed ID: 11380447
[TBL] [Abstract][Full Text] [Related]
40. Detection of procoagulant phospholipid interfering in tests for lupus anticoagulant.
Exner T; Low J
Thromb Res; 2004; 114(5-6):547-52. PubMed ID: 15507290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
